Re-evaluating the suitability of using fluoroquinolones in the treatment of infections in the context of FQ consumption and correlating changes to microorganism resistance levels in EU/EEA countries between 2016 and 2021.

Journal Information

Full Title: Naunyn Schmiedebergs Arch Pharmacol

Abbreviation: Naunyn Schmiedebergs Arch Pharmacol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethical approvalNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Author contributions: Piotr Serwacki and Jadwiga Wójkowska-Mach conceived the concept of the study and are corresponding authors. Piotr Serwacki, Mateusz Gajda and Jadwiga Wójkowska-Mach contributed to the design of the research. Mateusz Gajda contributed to the visualization of results. Piotr Serwacki, Mateusz Gajda, Wioletta Świątek-Kwapniewska, Marta Wałaszek, and Karolina Nowak were involved in data collection and analyzed the data. Jadwiga Wójkowska-Mach coordinated funding for the project. All authors edited and approved the final version of the manuscript. The authors declare that all data were generated in-house and that no paper mill was used."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025